← All trials
NCT05778877
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 19, 2022
- Primary completion
- Aug 31, 2025
- Completion date
- Aug 31, 2029
- First posted
- Mar 21, 2023
- Last posted
- May 8, 2023
- Enrollment
- 6
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Selecta Biosciences, Inc.Lead sponsor
- National Human Genome Research Institute (NHGRI)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.